Basal–Bolus Insulin Therapy with Gla-300 During Hospitalization Reduces Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study

INTRODUCTION: Although reduction in the incidence of nocturnal hypoglycemia, as estimated by symptom or self-monitored plasma glucose, was shown to be more pronounced with 300 units/mL insulin glargine (Gla-300) than with 100 units/mL insulin glargine (Gla-100) in type 2 diabetes patients, the exact...

Descripción completa

Detalles Bibliográficos
Autores principales: Okajima, Fumitaka, Nakamura, Yuko, Yamaguchi, Yuji, Shuto, Yuki, Kato, Katsuhito, Sugihara, Hitoshi, Emoto, Naoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984922/
https://www.ncbi.nlm.nih.gov/pubmed/29619751
http://dx.doi.org/10.1007/s13300-018-0419-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984922/
https://www.ncbi.nlm.nih.gov/pubmed/29619751
http://dx.doi.org/10.1007/s13300-018-0419-z

Ejemplares similares